Frontiers in Bioscience-Landmark,
Journal Year:
2024,
Volume and Issue:
29(5)
Published: May 11, 2024
Choline
participates
in
three
major
metabolic
pathways:
oxidation,
phosphorylation,
and
acetylation.
Through
choline
is
converted
to
betaine
contributes
methyl
metabolism
epigenetic
regulation.
phospholipid
metabolism,
serves
as
the
precursor
of
phosphocholine,
phosphatidylcholine,
glycerophosphocholine,
other
essential
compounds,
thereby
modulating
lipid
transport.
acetylation,
transformed
into
acetylcholine
cholinergic
neurons,
playing
a
vital
role
neurotransmission.
Moreover,
gut
microbiota
can
metabolize
trimethylamine-N-oxide,
be
involved
pathogenesis
various
diseases
such
nonalcoholic
fatty
liver
disease
(NAFLD),
cancer,
cardiovascular
disease,
etc.
Since
implicated
development
NAFLD
diverse
cancers,
including
it
may
serve
therapeutic
target
for
these
future.
Currently,
there
are
numerous
agents
targeting
treat
but
most
them
ineffective
some
even
have
adverse
effects
that
lead
series
complications.
Therefore,
further
research
clinical
validation
required
obtain
safe
efficacious
drugs.
This
review
comprehensively
summarizes
pathway
its
regulatory
mechanisms,
elucidates
roles
mechanisms
aforementioned
diseases,
provides
discussion
current
advances
immense
potential
this
field.
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(13), P. 7379 - 7379
Published: July 5, 2024
Short
chain
fatty
acids
(SCFAs),
mainly
including
acetate,
propionate
and
butyrate,
are
produced
by
intestinal
bacteria
during
the
fermentation
of
partially
digested
indigestible
polysaccharides.
SCFAs
play
an
important
role
in
regulating
energy
metabolism
maintaining
homeostasis
environment
also
regulatory
organs
tissues
outside
gut.
In
recent
years,
many
studies
have
shown
that
can
regulate
inflammation
affect
host
health,
two
main
signaling
mechanisms
been
identified:
activation
G-protein
coupled
receptors
(GPCRs)
inhibition
histone
deacetylase
(HDAC).
addition,
a
growing
body
evidence
highlights
importance
every
SCFA
influencing
health
maintenance
disease
development.
this
review,
we
summarized
advances
concerning
biological
properties
their
pathways
health.
Hopefully,
it
provide
systematic
theoretical
basis
for
nutritional
prevention
treatment
human
diseases.
EBioMedicine,
Journal Year:
2024,
Volume and Issue:
100, P. 104952 - 104952
Published: Jan. 4, 2024
Gut
probiotic
depletion
is
associated
with
non-alcoholic
fatty
liver
disease-associated
hepatocellular
carcinoma
(NAFLD-HCC).
Here,
we
investigated
the
prophylactic
potential
of
Lactobacillus
acidophilus
against
NAFLD-HCC.
Hepatology,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Feb. 13, 2024
Liver
cancer
is
the
third
leading
cause
of
cancer-related
deaths
and
ranks
as
sixth
most
prevalent
type
globally.
NAFLD
or
metabolic
dysfunction-associated
steatotic
liver
disease,
its
more
severe
manifestation,
NASH
steatohepatitis
(MASH),
pose
a
significant
global
health
concern,
affecting
approximately
20%-25%
population.
The
increased
prevalence
disease
MASH
parallel
to
increasing
rates
obesity-associated
diseases,
including
2
diabetes,
insulin
resistance,
fatty
diseases.
can
progress
MASH-related
HCC
(MASH-HCC)
in
about
2%
cases
each
year,
influenced
by
various
factors
such
genetic
mutations,
carcinogen
exposure,
immune
microenvironment,
microbiome.
MASH-HCC
exhibits
distinct
molecular
characteristics
compared
other
causes
affects
both
men
women
equally.
management
early
intermediate-stage
typically
involves
surgery
locoregional
therapies,
while
advanced
treated
with
systemic
anti-angiogenic
therapies
checkpoint
inhibitors.
In
this
comprehensive
review,
we
consolidate
previous
research
findings
also
providing
current
insights
into
intricate
processes
underlying
development.
We
delve
MASH-HCC-associated
variations
somatic
progression
models,
multiomics
analysis,
immunological
microenvironmental
impacts,
discuss
targeted/combined
overcome
evasion
biomarkers
recognize
treatment
responders.
By
furthering
our
comprehension
mechanisms
MASH-HCC,
goal
catalyze
advancement
potent
strategies,
ultimately
enhanced
patient
outcomes.
Gut,
Journal Year:
2024,
Volume and Issue:
74(1), P. 141 - 152
Published: June 29, 2024
Metabolic
dysfunction-associated
steatotic
liver
disease
(MASLD)
encompasses
a
wide
spectrum
of
injuries,
ranging
from
hepatic
steatosis,
metabolic
steatohepatitis
(MASH),
fibrosis,
cirrhosis
to
MASLD-associated
hepatocellular
carcinoma
(MASLD-HCC).
Recent
studies
have
highlighted
the
bidirectional
impacts
between
host
genetics/epigenetics
and
gut
microbial
community.
Host
genetics
influence
composition
microbiome,
while
microbiota
their
derived
metabolites
can
induce
epigenetic
modifications
affect
development
MASLD.
The
exploration
intricate
relationship
microbiome
genetic/epigenetic
makeup
is
anticipated
yield
promising
avenues
for
therapeutic
interventions
targeting
MASLD
its
associated
conditions.
In
this
review,
we
summarise
effects
alterations
in
MASLD-HCC.
We
further
discuss
research
findings
demonstrating
genetics/epigenetics,
emphasising
significance
interconnection
prevention
treatment.
Journal of Food Biochemistry,
Journal Year:
2024,
Volume and Issue:
2024, P. 1 - 23
Published: Feb. 7, 2024
Probiotics
have
growing
medical
importance
as
a
result
of
their
potential
in
the
prevention
and
therapeutic
support
several
complex
diseases,
including
different
types
cancers.
The
anticarcinogenic
properties
probiotics
are
attributed
to
various
mechanisms,
alterations
composition
intestinal
microbiota,
suppression
cell
proliferation,
stimulation
apoptosis,
inhibition
NF-kB,
reduction
levels
H2AX,
8-hydroxy-deoxyguanosine,
RIG-I,
downregulation
IL-17,
TNF
signaling
pathway.
Furthermore,
demonstrated
significant
advantages
management
other
diabetes,
obesity,
cardiovascular
diseases.
had
considerable
effect
reducing
inflammatory
infiltration
occurrence
precancerous
lesions.
Additionally,
administration
led
decrease
appearance
level
genes
related
proinflammatory
pathways,
NF-κB,
pathways.
However,
further
research
studies
required
comprehend
processes
via
which
exert
effects
authenticate
alternative
interventions.
Signal Transduction and Targeted Therapy,
Journal Year:
2025,
Volume and Issue:
10(1)
Published: Feb. 6, 2025
Abstract
Liver
cancer
represents
a
major
global
health
concern,
with
projections
indicating
that
the
number
of
new
cases
could
surpass
1
million
annually
by
2025.
Hepatocellular
carcinoma
(HCC)
constitutes
around
90%
liver
and
is
primarily
linked
to
factors
incluidng
aflatoxin,
hepatitis
B
(HBV)
C
(HCV),
metabolic
disorders.
There
are
no
obvious
symptoms
in
early
stage
HCC,
which
often
leads
delays
diagnosis.
Therefore,
HCC
patients
usually
present
tumors
advanced
incurable
stages.
Several
signaling
pathways
dis-regulated
cause
uncontrolled
cell
propagation,
metastasis,
recurrence
HCC.
Beyond
frequently
altered
therapeutically
targeted
receptor
tyrosine
kinase
(RTK)
involved
differentiation,
telomere
regulation,
epigenetic
modification
stress
response
also
provide
therapeutic
potential.
Investigating
key
their
inhibitors
pivotal
for
achieving
advancements
management
At
present,
primary
approaches
(TKI),
immune
checkpoint
(ICI),
combination
regimens.
New
trials
investigating
therapies
involving
ICIs
TKIs
or
anti-VEGF
(endothelial
growth
factor)
therapies,
as
well
combinations
two
immunotherapy
The
outcomes
these
expected
revolutionize
across
all
Here,
we
here
comprehensive
review
cellular
pathways,
potential,
evidence
derived
from
late-stage
clinical
discuss
concepts
underlying
earlier
trials,
biomarker
identification,
development
more
effective
therapeutics
Signal Transduction and Targeted Therapy,
Journal Year:
2025,
Volume and Issue:
10(1)
Published: Feb. 4, 2025
Abstract
As
a
highly
complex
organ
with
digestive,
endocrine,
and
immune-regulatory
functions,
the
liver
is
pivotal
in
maintaining
physiological
homeostasis
through
its
roles
metabolism,
detoxification,
immune
response.
Various
factors
including
viruses,
alcohol,
metabolites,
toxins,
other
pathogenic
agents
can
compromise
function,
leading
to
acute
or
chronic
injury
that
may
progress
end-stage
diseases.
While
sharing
common
features,
diseases
exhibit
distinct
pathophysiological,
clinical,
therapeutic
profiles.
Currently,
contribute
approximately
2
million
deaths
globally
each
year,
imposing
significant
economic
social
burdens
worldwide.
However,
there
no
cure
for
many
kinds
of
diseases,
partly
due
lack
thorough
understanding
development
these
Therefore,
this
review
provides
comprehensive
examination
epidemiology
characteristics
covering
spectrum
from
conditions
manifestations.
We
also
highlight
multifaceted
mechanisms
underlying
initiation
progression
spanning
molecular
cellular
levels
networks.
Additionally,
offers
updates
on
innovative
diagnostic
techniques,
current
treatments,
potential
targets
presently
under
clinical
evaluation.
Recent
advances
pathogenesis
hold
critical
implications
translational
value
novel
strategies.
International Journal of Molecular Sciences,
Journal Year:
2025,
Volume and Issue:
26(4), P. 1778 - 1778
Published: Feb. 19, 2025
In
recent
years,
“metabolic
dysfunction-associated
steatotic
liver
disease”
(MASLD)
has
been
proposed
to
better
connect
disease
metabolic
dysfunction,
which
is
the
most
common
chronic
worldwide.
MASLD
affects
more
than
30%
of
individuals
globally,
and
it
diagnosed
by
combination
hepatic
steatosis
obesity,
type
2
diabetes,
or
two
risk
factors.
begins
with
buildup
extra
fat,
often
greater
5%,
within
liver,
causing
hepatocytes
become
stressed.
This
can
proceed
a
severe
form,
steatohepatitis
(MASH),
in
20–30%
people,
where
inflammation
causes
tissue
fibrosis,
limits
blood
flow
over
time.
As
fibrosis
worsens,
MASH
may
lead
cirrhosis,
failure,
even
cancer.
While
pathophysiology
not
fully
known,
current
“multiple-hits”
concept
proposes
that
dietary
lifestyle
factors,
genetic
epigenetic
factors
contribute
elevated
oxidative
stress
inflammation,
fibrosis.
review
article
provides
an
overview
pathogenesis
evaluates
existing
therapies
as
well
pharmacological
drugs
are
currently
being
studied
clinical
trials
for
MASH.
Abstract
Recent
advances
in
understanding
the
modulatory
functions
of
gut
and
microbiota
on
human
diseases
facilitated
our
focused
attention
contribution
to
pathophysiological
alterations
many
extraintestinal
organs,
including
liver,
heart,
brain,
lungs,
kidneys,
bone,
skin,
reproductive,
endocrine
systems.
In
this
review,
we
applied
“gut–X
axis”
concept
describe
linkages
between
other
organs
discussed
latest
findings
related
axis,”
underlying
mechanisms
potential
clinical
intervention
strategies.